SOLIGENIX, INC. (SNGX)

↓ Download CSV

CIK 0000812796 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

Key ratios (FY2025)

-209.4%
Return on equity
Metric (FY)2025202420232022202120202019201820172016
Revenue$119.4K$839.4K$948.9K$824.3K$2.36M$4.63M$5.24M$5.43M$10.45M
Cost of Revenue$119.4K$742.0K$550.8K$728.6K$1.82M$3.57M$4.60M$4.31M$8.43M
Gross Profit$97.3K$398.1K$95.6K$538.5K$1.06M$643.7K$1.12M$2.02M
Operating Income-$11.85M-$9.44M-$7.70M-$14.24M-$13.10M-$18.59M-$10.54M-$9.06M-$7.59M-$5.71M
Net Income-$11.08M-$8.27M-$6.14M-$13.80M-$12.55M-$17.69M-$9.36M-$8.90M-$7.15M-$3.25M
EPS (Diluted)$-2.14$-4.98$-12.66$-4.81$-4.69$-0.64$-1.16$-1.34
Total Assets$9.24M$8.97M$9.80M$14.28M$26.87M$19.89M$7.78M$10.49M$9.55M$10.27M
Total Liabilities$3.94M$4.85M$7.27M$16.75M$16.15M$16.15M$6.32M$4.21M
Shareholders' Equity$5.29M$4.12M$2.52M-$2.47M$10.72M$3.74M$1.46M$6.28M$6.32M$7.40M
Cash & Equivalents$26.04M$18.68M$5.42M$8.98M$7.81M$8.77M
Operating Cash Flow-$10.27M-$8.40M-$8.60M-$12.65M-$11.74M-$11.45M-$7.51M-$7.24M-$6.51M-$4.98M
Capital Expenditures$5.9K
Shares Outstanding10.09M2.51M648.8K2.91M2.86M30.64M21.75M17.68M8.73M5.47M